Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022

BUY
$42.05 - $47.77 $206,255 - $234,311
4,905 Added 40.87%
16,906 $736,000
Q1 2022

May 03, 2022

BUY
$40.23 - $47.74 $12,954 - $15,372
322 Added 2.76%
12,001 $532,000
Q4 2021

Feb 08, 2022

BUY
$38.88 - $45.31 $55,909 - $65,155
1,438 Added 14.04%
11,679 $525,000
Q3 2021

Oct 19, 2021

BUY
$38.79 - $43.16 $1,551 - $1,726
40 Added 0.39%
10,241 $398,000
Q2 2021

Jul 23, 2021

BUY
$36.52 - $41.46 $32,868 - $37,314
900 Added 9.68%
10,201 $414,000
Q1 2021

Apr 23, 2021

SELL
$34.27 - $40.01 $40,849 - $47,691
-1,192 Reduced 11.36%
9,301 $338,000
Q4 2020

Jan 29, 2021

SELL
$34.07 - $39.94 $10,221 - $11,982
-300 Reduced 2.78%
10,493 $393,000
Q3 2020

Oct 22, 2020

SELL
$38.11 - $42.99 $3,811 - $4,299
-100 Reduced 0.92%
10,793 $414,000
Q2 2020

Jul 14, 2020

SELL
$37.87 - $43.58 $15,147 - $17,432
-400 Reduced 3.54%
10,893 $453,000
Q1 2020

Apr 17, 2020

SELL
$32.47 - $48.83 $30,521 - $45,900
-940 Reduced 7.68%
11,293 $436,000
Q4 2019

Jan 21, 2020

SELL
$42.0 - $48.25 $122,850 - $141,131
-2,925 Reduced 19.3%
12,233 $586,000
Q3 2019

Oct 28, 2019

SELL
$40.46 - $43.52 $8,092 - $8,704
-200 Reduced 1.3%
15,158 $647,000
Q2 2019

Jul 12, 2019

SELL
$39.4 - $42.7 $3,270 - $3,544
-83 Reduced 0.54%
15,358 $0
Q1 2019

Apr 26, 2019

BUY
$38.57 - $42.69 $24,877 - $27,535
645 Added 4.36%
15,441 $0
Q4 2018

Jan 08, 2019

BUY
$37.8 - $42.69 $6,161 - $6,958
163 Added 1.11%
14,796 $576,000
Q3 2018

Oct 04, 2018

SELL
$39.75 - $42.69 $41,856 - $44,952
-1,053 Reduced 6.71%
14,633 $0
Q2 2018

Jul 09, 2018

SELL
$39.61 - $42.76 $34,381 - $37,115
-868 Reduced 5.24%
15,686 $0
Q1 2018

Apr 04, 2018

SELL
$36.18 - $40.15 $43,705 - $48,501
-1,208 Reduced 6.8%
16,554 $0
Q4 2017

Jan 23, 2018

SELL
$35.34 - $41.9 $152,951 - $181,343
-4,328 Reduced 19.59%
17,762 $0
Q3 2017

Oct 17, 2017

BUY
$39.44 - $41.55 $871,229 - $917,839
22,090
22,090 $0

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.3B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Central Trust CO Portfolio

Follow Central Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Central Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Central Trust CO with notifications on news.